The Kim Ian Madsen Prostate Cancer Program
Literature, news and videos pertinent to
The Kim Ian Madsen Prostate Cancer Program
The Operating Room of the Future – Video regarding the pathbreaking work of InSightec
based in Tirat Carmel, Israel, www.insightec.com
- Check Out Prostate Cancer News Developments
- XTANDI® Patient Resources courtesy of Oncology Nurse Advisor
- New Drug Approved for Advanced Prostate Cancer
- Tiny capsule effectively kills cancer cells
- Coffee Consumption and Prostate Cancer
- Life-Saving DNA Test Overlooked in Rise of Colon Cancer
- Clinical Trials - Prostate Cancer - Advanced and Recurrent 2-19-2012
- Clinical Trials - Prostate Cancer - Metastatic 2-19-2012
- Medicare moves to pay for prostate cancer drug Provenge
- Study Knocks Diagnostic Value of PSA Velocity
- FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls
- Low-risk prostate cancer treated aggressively
- Predicting Risk Of Death From Prostate Cancer Via Baseline PSA
- New Target For Treatment Of Advanced Prostate Cancer
- Journal Of Geriatric Oncology Launched By Elsevier And International Society Of Geriatric Oncology
- Prostate Cancer Caused By a Virus?
- Toronto firm wins award for less-invasive prostate cancer therapy
The Kim Ian Madsen Prostate Cancer Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.
For more information about this special program, please click on...
Federal Tax I.D.: EIN 86-0818253